EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
01 1EUROAPI Hungary Ltd.
02 1MSN Laboratories Private Limited
01 1ILOPROST
02 1Iloprost
01 1France
02 1India
NDC Package Code : 82231-109
Start Marketing Date : 2018-09-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0017
Start Marketing Date : 2012-05-05
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Iloprost manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Iloprost, including repackagers and relabelers. The FDA regulates Iloprost manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Iloprost API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Iloprost manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Iloprost supplier is an individual or a company that provides Iloprost active pharmaceutical ingredient (API) or Iloprost finished formulations upon request. The Iloprost suppliers may include Iloprost API manufacturers, exporters, distributors and traders.
click here to find a list of Iloprost suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Iloprost as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Iloprost API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Iloprost as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Iloprost and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Iloprost NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Iloprost suppliers with NDC on PharmaCompass.
We have 2 companies offering Iloprost
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?